Introduction
============

Human coronaviruses (HCoVs) are positive-stranded, enveloped RNA viruses classified within the family Coronaviridae (genus, *Coronavirus*) ([@b9-bjm-44-335]). They are associated mainly with respiratory tract illness but are also involved in enteric and central nervous system diseases ([@b14-bjm-44-335]; [@b13-bjm-44-335]; [@b15-bjm-44-335]). Until recently only three human coronaviruses were thoroughly studied. Human coronavirus OC43 (HCoV-OC43) and human coronavirus 229E (HCoV-229E) were identified in the 1960s ([@b8-bjm-44-335]) and are well recognized as important pathogens that cause the common cold. A third novel human coronavirus, SARS-CoV, was identified as the causal agent during the 2002--2003 outbreak of severe acute respiratory syndrome (SARS) ([@b6-bjm-44-335]). The increase in research on these viruses soon led to discovery of 2 other human coronaviruses, HCoV-NL63 in the Netherlands and HCoV-HKU1 in China ([@b19-bjm-44-335]; [@b21-bjm-44-335]) both detected in respiratory tract specimens of patients with lower respiratory tract illnesses. Since July 2003 when the last case of SARS associated with the epidemic was reported only four human coronaviruses are known to continuously circulate in the human population. Results from epidemiological studies have led to the conclusion that these viruses are worldwide distributed and circulate with biennial prevalence ([@b11-bjm-44-335]; [@b17-bjm-44-335]; [@b18-bjm-44-335]; [@b4-bjm-44-335]; [@b7-bjm-44-335]). However, there are few studies that have described the epidemiological and clinical features of human coronaviruses infection among different populations, such as at-risk children or adults, patients with underlying conditions, those hospitalized, the immunocompromised patients and others, mainly in South America. In the present study, we retrospectively looked for the presence of HCoVs in different populations of Sao Paulo presenting acute respiratory tract infections (ARIs) from 2001 to 2010, to assess the prevalence that HCoVs infections have on different groups of Brazilian patients and to describe the clinical presentation of the ARIs caused by this virus and their circulation trends in Brazil.

Materials and Methods
=====================

Study design and population
---------------------------

During the nine-year span studied, respiratory samples were collected from patients presenting acute respiratory illnesses. The study period began in June 2001 and was concluded in September 2010. A total of 1,087 samples were collected. Specimens analyzed included 414 from nasopharyngeal swabs (Labor *Swab* Import, Brazil), 208 from nasal aspirations and 465 from nasal lavages. Subjects were: 50 adults who were attended by general-practice physicians among community population patients registered by the Medical Department Outpatient Office during 2001--2003, 86 healthcare workers (HCW) from Sao Paulo Hospital during 2001--2003, 148 renal transplanted patients registered at the Outpatient Office of the Nephrology Division of Sao Paulo Federal University during 2002--2004, 81 children with heart diseases from the pediatric cardiac ambulatory unit of Sao Paulo Federal University during 2005--2008, 329 children outpatients from the general community from the pediatric ambulatory unit of Sao Paulo Federal University during 2008--2010, 181 patients under stem cell transplantation program registered at the Hematologic Division of São Paulo Hospital during 2008--2009 and 212 hospitalized patients originally suspected of H1N1 2009 infection at Sao Paulo Hospital during 2009--2010.

Inclusion criteria
------------------

Three inclusion criteria were used: patients with a clinical diagnosis of Influenza-Like-Illness (ILI) defined by the presence of fever plus at least one respiratory symptom (cough and/or sore throat) and one constitutional symptom (headache, myalgia, sweat or chills); patients with a clinical diagnosis of Acute Respiratory Infection (ARI) defined by the presence of respiratory symptoms who did not fulfill ILI definition were considered to have ARI; hospitalized patients suspected of 2009 H1N1 Influenza A infection presenting fever \< 38 °C, cough and dyspnea. Lower respiratory tract illness was defined as having 1 of the following: supplemental oxygen requirement, mechanical ventilation requirement, or a chest radiograph showing possible or definite infiltrates.

Demographic and clinical data
-----------------------------

Epidemiological and clinical data from outpatients were obtained using a standardized questionnaire while data from hospitalized patients were abstracted from medical charts using a standardized form. Age, gender, occupation, presence of underlying conditions or diseases, clinical findings at first attendance (for outpatients) or during the first 24 hours (for hospitalized patients) were recorded for analysis. Institutional review board approval was received before reviewing any records. This study was approved by the Ethics Committee of Sao Paulo Federal University (CEP 1968/09), and written consent was obtained from all patients or those responsible for the individual patient.

Pancoronavirus RT-PCR one-step assay
------------------------------------

Viral genomic RNA was extracted from the collected specimens by using a QIAamp Viral RNA extraction kit (QIAGEN, Valencia, CA), according to the instructions of the manufacturer. A pancoronavirus RT-PCR assay previously described ([@b20-bjm-44-335]) with just minor modifications (50 cycles of amplification to 40 and melting temperature from 48 °C to 50 °C), was performed in order to detect human and animal coronaviruses in the samples. The amplification of a 251 bp fragment of the polymerase gene was performed using the following primer set: Cor-FW (5′-ACWCARHTVAAYYTNAARTAYGC-3′) and Cor-RV (5′-TCRCAYTTDGGRTARTCCCA-3′). These one-step RT-PCR assays (OneStep RT-PCR kit; QIAGEN) were undertaken in a 50 μL reaction volume containing 10 μL RNA-extract, 10 μL 5x QIAGEN OneStep RT-PCR Buffer, 2 μL dNTP mix (final concentration of 400 μM of each dNTP), 1.8 μL QIAGEN OneStep RT-PCR Enzyme Mix (a combination of Omniscript and Sensiscript reverse transcriptase and Hot- StarTaq DNA polymerase), 4 μM of each primer, and RNase-free water to 50 μL. Positive and negative controls were included in each PCR experiment. The reaction was carried out with an initial reverse transcription step at 50 °C for 30 min, followed by PCR activation at 95 °C for 15 min, 40 cycles of amplification (30 sec at 94 °C; 30 sec at 50 °C; 1 min at 72 °C), and a final extension step at 72 °C for 10 min in a VERITI thermal cycler (Applied Biosystems, Foster City, CA, USA). PCR-products were verified on an agarose gel, stained with ethidium bromide, and visualized under UV-light.

Statistical analysis
--------------------

Statistical analysisconsisted of Pearsons chi-square test for the comparison of categorical values, with a significance level of p \< 0.050. Non-conditional logistic regression was used to identify associations between coronaviruses positivity and the studied populations. All reported values were two-tailed. Results were presented as odds ratio (OR) and therespective 95% confidence interval (CI) and pvalue. All data were entered into and analyzed by using SPSS version 11.0 (SPSS Inc., Chicago, IL, USA).

Results
=======

Coronaviruses were detected in 126 (11.5%) of 1,087 specimens using the Pancoronavirus RT-PCR assay. Coronaviruses were detected in every month except January with a 20.3% peak on winter months (July) ([Figure 1](#f1-bjm-44-335){ref-type="fig"}). Peaks detection frequency was observed during 2002--2004 and 2008--2009, with the highest detection in 2008 ([Figure 1](#f1-bjm-44-335){ref-type="fig"}). Coronaviruses-positive cases were found from patients ranging in age from 2 months to 80 years, with a median age of 33 years. The majority (59%) was female. Twenty percent of coronaviruses-infected patients presented underlying diseases other than cardiac and/or transplanted conditions. Fifteen patients had hypertension, 5 had diabetes mellitus, 1 patient was HIV infected and 1 had congenital kidney disease. The prevalence of HCoV was higher among children with heart diseases (24.6%), patients under stem cell transplantation program (24.3%) and renal transplanted patients (20.2%) than others patients groups. Adults from community and healthcare workers showed similar infection rates despite of the occupational risk of the last group. The lowest ratios of coronaviruses-positive cases were obtained in children from community and hospitalized patients, 3.3% and 1.8%, respectively ([Table 1](#t1-bjm-44-335){ref-type="table"}). Coronaviruses-infection was significantly different (p \< 0.05) among the studied populations. Children with heart diseases presented the highest risk of acquiring coronavirus infection (OR = 17.0; 95% CI 5.6 -- 51.8; p ≤ 0.0001) when compared with the other populations by logistic regression analysis.

Coryza, cough and fever were the most common symptoms at presentation, reported in 86%, 80% and 49% of positive cases, respectively. Clinical characteristics of coronaviruses-infected patients are shown in [Table 2](#t2-bjm-44-335){ref-type="table"}. Differences on clinical expressions were obtained among the studied populations (p \< 0.05). Fever was less found among both renal and patients under stem cell transplantation program when compared with the other groups. Cyanosis was only reported in 1 child with heart disease and wheezing was reported only among hospitalized patients and children, both from community and with heart diseases. Dyspnea, another lower respiratory tract infection symptom besides wheezing, was documented among patients under stem cell transplantation program, children with heart diseases, children from community and hospitalized patients. Healthcare workers presented more sore throat and myalgia than the other studied populations.

Discussion
==========

Viral respiratory diseases are the leading cause of medical attendance worldwide exerting a great economic impact on the health-care system. Human coronavirus is considered one of the most common respiratory viruses associated with respiratory tract infections, mainly among children. Epidemiological and clinical data of HCoVs infectious in the Brazilian population are scarce and restricted to one or two group of patients. [@b2-bjm-44-335] reported 4.2% of human coronaviruses in Brazilian adults, [@b22-bjm-44-335] described a fatal case of HCoV-NL63 associated with pneumonia in a Brazilian adult and [@b1-bjm-44-335] reported 1.9% among Brazilian children. This is the first Brazilian report of HCoVs from distinct Brazilian population over a period of nine years.

Detection of coronaviruses by culture isolation or serological methods is difficult. A pancoronavirus RT-PCR assay is a usefull molecular tool to test for all coronaviruses in a clinical sample. In addition, quick screening for several pathogens in one assay allows the identification of previously unknown coronaviruses. However, the pancoronavirus RT-PCR assay used could have led to some limitations in our study. First, HCoVs subtypes were not identified and the prevalence of our study could be overestimated and/or underestimated once the assay included non specific primers that target all human and animal coronaviruses. Therefore, the use of degenerate primers set in a conventional RT-PCR may enhance detection of coronavirus genome variations, but may also miss samples with less genome copies. To have a better understanding about it and mainly to rule out the possibility of a bias, we sequenced a portion of the coronaviruses positive cases detected in the present study using pancoronavirus primers set. The positive cases detected among hospitalized patients from 2009 to 2010 were sequenced and all samples were confirmed as human coronaviruses ([@b23-bjm-44-335]).

Coronaviruses can display a typical biennial seasonality different than occur with other respiratory viruses ([@b11-bjm-44-335]; [@b12-bjm-44-335]; [@b17-bjm-44-335]). In this regard, we identified peaks of detection frequency of HCoVs during 2002--2004 and 2008--2009, with high detection frequencies in winter months but few or no detections in the summer.

The prevalence of 11.5% found in our study corroborated with other research that identified coronaviruses as responsible for 10--30% of common colds and 0.3--9% associated with pneumonia ([@b16-bjm-44-335]; [@b3-bjm-44-335]; [@b10-bjm-44-335]; [@b5-bjm-44-335]). We demonstrate the presence of HCoVs infection in all studied populations, with a significant prevalence among some at-risk group patients, such as patients under stem cell transplantation program and children with heart diseases. This higher frequency of HCoVs may be related to the functional condition of these patients. On the other hand, a lower prevalence was observed among children from community when compared with our different studied populations. Since the majority of these children presented influenza-like illness instead of common cold symptoms, the clinical pattern can explain this lower frequency among this group of patients. Underlying conditions other than cardiac/transplantation were observed among 20% of coronaviruses-infected patients. This data along with the higher prevalence of coronaviruses-infected cases found in specific at-risk group patients pointed to the relevance of coronaviruses causing respiratory tract illness in patients with comorbidities.

In conclusion, our results provided a novel insight into the epidemiology and clinical knowledge of coronaviruses in different groups of the Brazilian population, supporting the notation that HCoV may have an important role among patients with underlying conditions and transplanted ones.
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###### 

Human coronaviruses infections among Brazilian patients during 9 years of surveillance.

  Populations             Tested, no.   Positive specimens   OR        95% CI
  ----------------------- ------------- -------------------- --------- ------------
  Adults                  50            6 (12)               7.1       3.0--21.0
  HCW                     86            11 (12.8)            7.6       5.7--19.9
  Renal TPL               148           30 (20.3)            13.2      13.8--26.8
  Children heart dis      81            20 (24.7)            17.0      15.3--34.1
  SCTP                    181           44 (24.3)            16.7      18.1--30.1
  Comm. children          329           11 (3.3)             1.8       1.4--5.3
  Hospitalized patients   212           4 (1.9)              1 (Ref)   0.1--3.7
  Total                   1087          126 (11.6)                     9.7--13.5

Note. HCW: healthcare workers; renal TPL: renal transplanted patients; children heart dis: children with heart diseases; SCTP: patients under stem cell transplantation program; comm. children: children from community; CI: confidence intervals; OR: odds ratio.

###### 

Clinical data of coronaviruses-infected patients, 2001--2010.

  Populations                                                
  ------------- ------- ------- ------- ------ ------ ------ -------
  Fever         83.3    72.7    81.8    50.0   23.3   41.4   100.0
  Cough         83.3    81.8    100.0   90.0   71.4   72.0   100.0
  Wheezing      \-      \-      27.2    25.0   \-     0      25.0
  Cyanosis      \-      \-      0       5.0    \-     0      0
  Dyspnea       \-      \-      27.2    25.0   \-     30.0   50.0
  Coryza        100.0   90.9    100.0   90.0   86.6   81.3   25.0
  Sore throat   33.3    81.8    0       0      28.5   15.0   25.0
  Headache      100.0   100.0   0       0      46.4   18.9   25.0
  Diarrhea      0       0       0       0      0      2.6    25.0
  Myalgia       83.3    90.9    9.0     0      32.1   17.9   25.0

Note. HCW: healthcare workers; Renal TPL: renal transplanted patients; children heart: children with heart diseases; SCTP: patients under stem cell transplantation program; com children: children from community; hospitalized: hospitalized patients.
